Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
A new study shows that the aromatase inhibitor letrozole can prevent late recurrence of breast cancer. References and Resources Goss P, et al. Late extended adjuvant treatment with…
Statin use at the time of ovarian cancer surgery was associated with a 50% increase in the duration of progression-free survival and with more than a year of…
The Oncologic Drug Advisory Committee said the FDA should mandate a restricted distribution system for cancer patients given erythropoiesis-stimulating agents. References and Resources FDA.gov Sponsored by The Doctor’s…
Results of a Gynecologic Oncology Group study suggest that for patients with recurrent cervical cancer, bevacizumab has demonstrated activity and promise as an option for second or third…
Erythropoiesis-stimulating agent administration to patients with cancer is associated with increased risks of VTE and mortality. References and Resources Bennett C., Silver S., Djulbegovic B., et al. Venous…
The FDA has issued an update to inform the public that Baxter Healthcare Corporation has extended its recall of multi-dose vials of heparin sodium for injection to also…
DNA methylation may provide clues to boost detection of prostate cancer and prevent unnecessary biopsies according to a prospective study presented at the American Society of Clinical Oncology…
Mary Wright, MD, Associate Professor & Director, Breast Center, Section of Breast Surgery, Department of Surgery, Tulane University School of Medicine, discusses post mastectomy breast reconstructive surgery. References…
Mary Wright, MD, Associate Professor & Director, Breast Center, Section of Breast Surgery, Department of Surgery, Tulane University School of Medicine, discusses the uniqueness of a breast cancer…
The results of a phase II, multicenter trial that included 25 adult patients with newly diagnosed disease reported that patients maintained a complete response to treatment with high-dose…
